These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32751564)

  • 81. Combined steroidogenic characters of fetal adrenal and Leydig cells in childhood adrenocortical carcinoma.
    Fujisawa Y; Sakaguchi K; Ono H; Yamaguchi R; Kato F; Kagami M; Fukami M; Ogata T
    J Steroid Biochem Mol Biol; 2016 May; 159():86-93. PubMed ID: 26940356
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Clinicopathological features, biochemical and molecular markers in 5 patients with adrenocortical carcinoma.
    Kouyama R; Hiraishi K; Sugiyama T; Izumiyama H; Yoshimoto T; Akashi T; Kihara K; Homma K; Shibata H; Hirata Y
    Endocr J; 2011; 58(7):527-34. PubMed ID: 21521927
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Optimization of the First Selective Steroid-11β-hydroxylase (CYP11B1) Inhibitors for the Treatment of Cortisol Dependent Diseases.
    Hille UE; Zimmer C; Haupenthal J; Hartmann RW
    ACS Med Chem Lett; 2011 Aug; 2(8):559-64. PubMed ID: 24900349
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Estimation of the Mechanism of Adrenal Action of Endocrine-Disrupting Compounds Using a Computational Model of Adrenal Steroidogenesis in NCI-H295R Cells.
    Saito R; Terasaki N; Yamazaki M; Masutomi N; Tsutsui N; Okamoto M
    J Toxicol; 2016; 2016():4041827. PubMed ID: 27057163
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The Potential of Steroid Profiling by Mass Spectrometry in the Management of Adrenocortical Carcinoma.
    Rossi C; Cicalini I; Verrocchio S; Di Dalmazi G; Federici L; Bucci I
    Biomedicines; 2020 Aug; 8(9):. PubMed ID: 32872281
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The influence of TNF-α on the expression profile of key enzymes of steroidogenesis in H295R cells.
    Grabarek B; Cholewa K; Lodowska J
    Postepy Dermatol Alergol; 2021 Jun; 38(3):404-411. PubMed ID: 34377120
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Upregulation of TCF21 inhibits migration of adrenocortical carcinoma cells.
    Kremer JL; Auricino TB; Dos Santos Passaia B; Lotfi CFP
    Discov Oncol; 2021 Jul; 12(1):23. PubMed ID: 35201460
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACC.
    Doghman-Bouguerra M; Finetti P; Durand N; Parise IZS; Sbiera S; Cantini G; Canu L; Hescot S; Figueiredo MMO; Komechen H; Sbiera I; Nesi G; Paci A; Al Ghuzlan A; Birnbaum D; Baudin E; Luconi M; Fassnacht M; Figueiredo BC; Bertucci F; Lalli E
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32183347
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Feminizing adrenal tumor identified by plasma steroid profiling.
    Vogt EC; Hammerling K; Sorbye H; Heie A; Sulen A; Ueland G; Husebye E; Methlie P
    Endocrinol Diabetes Metab Case Rep; 2021 Nov; 2021():. PubMed ID: 34845109
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Influence of sex and functional status on the value of serum steroid profiling in discriminating adrenocortical carcinoma from adrenocortical adenoma.
    Weng Y; Tang JY; Zhang XY; Lin DZ; Guo Y; Liang Y; Wang L; Zhou J; Yan L; Lin TX; Zhang SL
    Front Endocrinol (Lausanne); 2024; 15():1435102. PubMed ID: 39359414
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Diagnostic and prognostic assessments of adrenocortical carcinomas by pathological features, immunohistochemical markers and reticular histochemistry staining.
    Gan W; Han X; Gong Y; Yang Y; Wang C; Zhang Z
    Diagn Pathol; 2024 May; 19(1):71. PubMed ID: 38802933
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Adrenal Hemorrhage in a Cortisol-Secreting Adenoma Caused by Antiphospholipid Syndrome Revealed by Clinical and Pathological Investigations: A Case Report.
    Ochi K; Abe I; Yamazaki Y; Nagata M; Senda Y; Takeshita K; Koga M; Yamao Y; Shigeoka T; Kudo T; Fukuhara Y; Miyajima S; Taira H; Haraoka S; Ishii T; Takashi Y; Lam AK; Sasano H; Kobayashi K
    Front Endocrinol (Lausanne); 2021; 12():769450. PubMed ID: 35185780
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Future Directions in Diagnosis, Prognosis and Disease Monitoring of Adrenocortical Carcinoma: Novel Non-Invasive Biomarkers.
    Cheng Y; Kou W; Zhu D; Yu X; Zhu Y
    Front Endocrinol (Lausanne); 2021; 12():811293. PubMed ID: 35178030
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Re-Evaluation of Combinational Efficacy and Synergy of the Italian Protocol In Vitro: Are We Truly Optimizing Benefit or Permitting Unwanted Toxicity?
    Subramanian C; McCallister R; Kuszynski D; Cohen MS
    Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572375
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives.
    Mizdrak M; Tičinović Kurir T; Božić J
    Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33578890
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Incomplete Pattern of Steroidogenic Protein Expression in Functioning Adrenocortical Carcinomas.
    Pereira SS; Costa MM; Gomez-Sanchez CE; Monteiro MP; Pignatelli D
    Biomedicines; 2020 Jul; 8(8):. PubMed ID: 32751564
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Disorganized Steroidogenesis in Adrenocortical Carcinoma, a Case Study.
    Uchida T; Nishimoto K; Fukumura Y; Asahina M; Goto H; Kawano Y; Shimizu F; Tsujimura A; Seki T; Mukai K; Kabe Y; Suematsu M; Gomez-Sanchez CE; Yao T; Horie S; Watada H
    Endocr Pathol; 2017 Mar; 28(1):27-35. PubMed ID: 27430645
    [TBL] [Abstract][Full Text] [Related]  

  • 98. H-score of 11β-hydroxylase and aldosterone synthase in the histopathological diagnosis of adrenocortical tumors.
    Yang Y; Xiao M; Song Y; Tang Y; Luo T; Yang S; He W; Cheng Q; Ma L; Zhang Y; He Y; Cao Y; Yang J; Peng B; Hu J; Li Q
    Endocrine; 2019 Sep; 65(3):683-691. PubMed ID: 31332713
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Expression of steroidogenic enzymes and their transcription factors in cortisol-producing adrenocortical adenomas: immunohistochemical analysis and quantitative real-time polymerase chain reaction studies.
    Kubota-Nakayama F; Nakamura Y; Konosu-Fukaya S; Azmahani A; Ise K; Yamazaki Y; Kitawaki Y; Felizola SJ; Ono Y; Omata K; Morimoto R; Iwama N; Satoh F; Sasano H
    Hum Pathol; 2016 Aug; 54():165-73. PubMed ID: 27085553
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Disorders of the aldosterone synthase and steroid 11beta-hydroxylase deficiencies.
    Peter M; Dubuis JM; Sippell WG
    Horm Res; 1999; 51(5):211-22. PubMed ID: 10559665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.